TY - JOUR
T1 - Evolutionary implications of a new bypass activation pathway of the complement system
AU - Farries, Timothy C.
AU - Lee Knutzen Steuer, K.
AU - Atkinson, John P.
N1 - Funding Information:
t"h~s work was supported by grants f gm HHMI. NIH, Ajtnomoto Co. and the American Cancer Socic~'. J.J.L. is supported by Conselho Naoonal de Pesquisas (CNPq), Brazil I Tonegawa, S. (1983) Nature 302, 575-581 2 Lederberg, J. (1959) Science 129, 1649-1653 3 Jeme, N.K. (1970)Eur. I IrnmuncL 1, 1-9 4 Bevan. M.J. (1977) Nature 269, 417-420 $ yon Boehmer, H., Haas, W. and Jerne, N.K. (1978) Proc. Nail Acad. ScL USA 75, 243_°-2442 6 Teh. H.S., Kisielow, P., Scott, B. et aL (1988) Nature 335, 229-233 7 Kisielow, P., Teh, H-S., Bauthmann, H. and yon Boehmer, H. (1988) Na,~jre 335, 730--733 8 Davis, M.M. and B|orkman, P.J. (1988) Nature 334, 395-402 9 Takagaki, Y., Nakan~shi, N., Ishid,~, I., Kanagawa, O. and Tonegawa, S. (1939)1 ImrnunoL 142, 2112-2121 10 Takagaki, Y., DeCIoux, A., Bonneville, M. and Tonegawa, S. (1969) Nature 339, 712-714 11 Lafaille, J.J., DeCloux, A., Bonneville, M., Takagaki, Y. and Tonegawa, S. (1989) Cell 59, 859-870 12 Itohara, S., Farr, A.G., Lafaille, JJ. et al. Nature (in press) 13 Elliott, J.F., Rock, E.P., Patten, P.A., Davis, M.M. and Chien, Y-H. (1988) Nature 331,627-631 14 Asarnow, D.M., Kuziel, W.A, Bonyhadi, M. et aL (1988) Cell 55 837-847 !5 Lacy, M.J., McNeil, L.K., Roth, M.E. and Kranz, D.M. (1989) Proc. Natl Acad. Sci. USA 86, 1023-1026 16 Kyes, S., Carew, E., Carding, S.R., Janeway, C.A. and Hayday, A. (1989) Proc. NatlAcad. Sci. USA 86, 5527-5531 17 Asarnow, D.M., Goooman, T., LeFran(;ois, L and Allison, J.P. (1989) Nature 341, 60-62 18 Tonegawa, S, Berns, A., Bonneville, M et aL Cold Spring Harbor Syrup. Quant. BioL (in press) 19 Home, C., Klein, M., Polidoulis, I. and Dorrington, K.J. (1982) J. ImmunoL 129, 660-664 20 Marrack, P., Lo, D., Brinster, R. et aL (1988) Cell 53, 627-634 21 Matis, L.A., Cron, R. and Bluestone, J.A. (1987) Nature 330, 262-265 22 Bonneville, M., Ito, K., Krecko, E.G. et aL (1989) Proc. Natl Acad. Sci. USA 86, 5928-5932 23 Janewa~/, C.A., Jr, Jones, B. and Hayday, A. (1988) IrnmunoL Today 9, 73-76
PY - 1990
Y1 - 1990
N2 - The classical pathway of complement activation is a highly specific and amplifiable effector system responding to recognition of foreign antigens by antibody. It comprises a group of well characterized proteins in mammalian plasma. There are many similarities with the alternative pathway of complement activation, which suggests that they have a common evolutionary origin. Both pathways have homologous components, use related activation and regulatory mechanisms, result in the release of the anaphylatoxins C3a and C5a, and deposit C3b onto activating surfaces. This fixed C3b then becomes the focus of further immune reactions, involving either the lytic complement components of C3b receptors on effector cells. Phylogenetic data indicate that the alternative pathway is the older, and that the classical pathway evolved from it. Here Timothy Farries and colleagues review this evolutionary process and present a possible sequence of events that is suggested by recent functional data from their laboratory.
AB - The classical pathway of complement activation is a highly specific and amplifiable effector system responding to recognition of foreign antigens by antibody. It comprises a group of well characterized proteins in mammalian plasma. There are many similarities with the alternative pathway of complement activation, which suggests that they have a common evolutionary origin. Both pathways have homologous components, use related activation and regulatory mechanisms, result in the release of the anaphylatoxins C3a and C5a, and deposit C3b onto activating surfaces. This fixed C3b then becomes the focus of further immune reactions, involving either the lytic complement components of C3b receptors on effector cells. Phylogenetic data indicate that the alternative pathway is the older, and that the classical pathway evolved from it. Here Timothy Farries and colleagues review this evolutionary process and present a possible sequence of events that is suggested by recent functional data from their laboratory.
UR - http://www.scopus.com/inward/record.url?scp=0025191380&partnerID=8YFLogxK
U2 - 10.1016/0167-5699(90)90031-4
DO - 10.1016/0167-5699(90)90031-4
M3 - Article
C2 - 2186743
AN - SCOPUS:0025191380
SN - 0167-5699
VL - 11
SP - 78
EP - 80
JO - Immunology today
JF - Immunology today
IS - C
ER -